Skip to main content

Tolany Brandon's Form 4 filing

Silicon Laboratories Inc.SLAB · filed Aug 20, 2025

Accession no.
0001628280-25-040852
Filed
Aug 20, 2025
Trade date
Aug 19, 2025
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $301.2K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tolany BrandonCIK 0001586469Officer (Sr VP WW Sales & Marketing)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 19, 2025Common Stock, $0.0001 par valueMOption exerciseAcquired+35$43.82+$1,533.762,363Direct
Aug 19, 2025Common Stock, $0.0001 par valueMOption exerciseAcquired+2,235$43.82+$97,937.764,598Direct
Aug 19, 2025Common Stock, $0.0001 par valueSSaleDisposed−2,270$132.69−$301,206.362,328Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 19, 2025Common Stock, $0.0001 par valueMOption exerciseDisposed−35–F1–18,235Direct
Aug 19, 2025Common Stock, $0.0001 par valueMOption exerciseDisposed−2,235–F1–16,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Not applicable per instruction 4(c)(iii).

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)